Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Current concerns are idiosyncratic: most reviews have confirmed the vaccine's safety
| The first 150 words of the full text of this article appear below. |
The current low uptake of measles, mumps, and rubella (MMR) vaccine in some parts of the United Kingdom has led to well publicised concerns about the potential for measles outbreaks among primary school entrants. This has coincided with prepublication publicity last week of a paper casting doubts on the adequacy of the evidence which secured the licence for MMR vaccine.1 Understandably some parents and health professionals are confused and anxious and, in an effort to protect their children against measles, have sought single antigen vaccines. We have reviewed the latest developments in this saga and are convinced that such confusion and anxiety about MMR vaccine are unfounded.
The authors of the paper, Wakefield and Montgomery, imply that they
have examined all the safety data relating to the licensing of the
vaccine1 in the early 1970s (1971 in US and 1972 in UK,
not 1975 and 1988 as they say). Although this is their aim,
Read all Rapid Responses